SGS Biologics Services

Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.

Events

In-Person & Online Events

Pivotal moments where high-level industry experts and thought leaders come together for focused knowledge sharing and unparalleled networking opportunities.

Online Activities

Our Monthly Science Exchanges and Webinars keep you connected to the conversation.

All Online Activities
Community

Speakers

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

More Info

Sponsors

Our range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

More Info

Media Partners

We work with leading journal publications on reciprocal marketing arrangements.

More Info
Services

In-Person Services

At Oxford Global, our events are designed to connect key life science figures and innovative solution providers, accelerating scientific advancement. Our goal is to create valuable connections and an impactful experience through innovative and collaborative formats.

More Info

Digital Marketing Services

Oxford Global’s products offer a powerful channel to associate your brand with the latest advancements within the industry whilst educating and influencing the industry throughout their buying process.

More Info
Resources

Browse All Resources

The latest in cell & gene research, from advanced therapies through to the latest developments in cell & gene research, therapies & manufacturing.

All Cell & Gene Resources

Latest Resources

Q&A with Terri Gaskell, Chief Technology Officer, Rinri Therapeutics

08/10/24 - We catch up with Terri Gaskell from Rinri Tx to discuss how they are reversing hearing loss using stem cell based regenerative medicine.

10/09/24 - Kyoto University Hospital Explores the Potential of Treating Type 1 Diabetes Using Induced Pluripotent Stem Cells

05/08/24 - Jaguar Gene's JAG201 Therapy Trial for SHANK3 Haploinsufficiency Receives FDA Approval
PLUS Pass
Contact
Our Brands

Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.

Oxford Global

Precision Medicine

Discovery & Development

NextGen Biomed